Michael M. Allevato

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4

Zhiyong Wang, Victoria H. Wu, Michael M. Allevato et al. · Nature Communications · 2019 · 166 citations · Full text

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

Robert Saddawi‐Konefka, Aoife O’Farrell, Farhoud Faraji et al. · Nature Communications · 2022 · 152 citations · Full text

Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer

Zhiyong Wang, Yusuke Goto, Michael M. Allevato et al. · Nature Communications · 2021 · 83 citations · Full text

Neck Cancer, Pd-1 Blockade, Medicine +11

4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer

Zhiyong Wang, Xiaodong Feng, Alfredo Molinolo et al. · Cancer Research · 2019 · 81 citations · Full text

Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs

Michael M. Allevato, Eugene Bolotin, Mark H. Grossman et al. · PLoS ONE · 2017 · 60 citations · Full text

Genetics, Sequence-specific Dna Binding, Molecular Biology +18